FDA Inspection 907096 — Biotest Pharmaceuticals Corporation

Biotest Pharmaceuticals Corporation — FEI 1627241

The FDA completed an inspection of Biotest Pharmaceuticals Corporation on December 12, 2014 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 12, 2014
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
San Antonio, TX (United States)